• Exchange: BM&FBOVESPA
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AMGN34:BZ

267.040 BRL 7.890 3.04%

As of 11:37:21 ET on 07/22/2014.

Snapshot for Amgen Inc (AMGN34)

Open: 267.040 Day's Range: 267.040 - 267.040 Volume: 800
Previous Close: 259.150 52wk Range: 235.740 - 300.610 1-Yr Rtn: -

Stock Chart for AMGN34

No chart data available.
  • AMGN34:BZ 267.040
  • 1D
  • 1M
  • 1Y
259.150
Interactive AMGN34 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AMGN34

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. IBOV -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M BRL) 202,155.06
Shares Outstanding (M) 757.02
30 Day Average Volume 27
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.87%
Cash Dividend (BRL) 0.9196
Dividend Ex-Date 08/12/2014
5 Year Dividend Growth -
Next Earnings Announcement 10/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AMGN34

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AMGN34

Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.

Robert A Bradway "Bob"Chairman/President/CEODavid W MelineExec VP/CFO
Anthony C Hooper "Tony"Exec VP:Global Commercial OpsBrian M McNameeExec VP:Full Potential Initiatives
More Company Profile & Key Executives for AMGN34

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil